146 related articles for article (PubMed ID: 2861221)
1. Mediator release in local heat urticaria: protection with combined H1 and H2 antagonists.
Irwin RB; Lieberman P; Friedman MM; Kaliner M; Kaplan R; Bale G; Treadwell G; Yoo TJ
J Allergy Clin Immunol; 1985 Jul; 76(1):35-9. PubMed ID: 2861221
[TBL] [Abstract][Full Text] [Related]
2. Combined H1 and H2 antihistamine therapy in chronic urticaria.
Monroe EW; Cohen SH; Kalbfleisch J; Schulz CI
Arch Dermatol; 1981 Jul; 117(7):404-7. PubMed ID: 6114712
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic idiopathic urticaria with combined H1 and H2 blockers.
Phanuphak P; Schocket A; Kohler PF
Clin Allergy; 1978 Sep; 8(5):429-33. PubMed ID: 30546
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of idiopathic cold urticaria with the association of H1 and H2 antagonists: a case report.
Duc J; Pécoud A
Ann Allergy; 1986 Apr; 56(4):355-7. PubMed ID: 2870670
[TBL] [Abstract][Full Text] [Related]
5. Greater inhibition of dermographia with a combination of H1 and H2 antagonists.
Mansfield LE; Smith JA; Nelson HS
Ann Allergy; 1983 Apr; 50(4):264-5. PubMed ID: 6132569
[TBL] [Abstract][Full Text] [Related]
6. The effect of H1 and H2 blockade on cutaneous histamine response in man.
Harvey RP; Schocket AL
J Allergy Clin Immunol; 1980 Feb; 65(2):136-9. PubMed ID: 6101337
[TBL] [Abstract][Full Text] [Related]
7. Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines.
Ujiie H; Shimizu T; Natsuga K; Arita K; Tomizawa K; Shimizu H
Clin Exp Dermatol; 2006 Jul; 31(4):588-9. PubMed ID: 16716168
[No Abstract] [Full Text] [Related]
8. H1- and H2-antagonists in allergic and pseudoallergic diseases.
Ring J; Behrendt H
Clin Exp Allergy; 1990 Aug; 20 Suppl 2():43-9. PubMed ID: 1977507
[TBL] [Abstract][Full Text] [Related]
9. Management of cold urticaria during hypothermic cardiopulmonary bypass.
Johnston WE; Moss J; Philbin DM; Guiney TE; Sisson JH; Buckley MJ; Lowenstein E
N Engl J Med; 1982 Jan; 306(4):219-21. PubMed ID: 6119612
[No Abstract] [Full Text] [Related]
10. H2 antihistamines (cimetidine) and allergic-inflammatory reactions.
Norn S; Permin H; Skov PS
Allergy; 1980 Jun; 35(4):357-61. PubMed ID: 6160781
[TBL] [Abstract][Full Text] [Related]
11. H1 + H2-receptor antagonists for premedication in anaesthesia and surgery: a critical view based on randomized clinical trials with Haemaccel and various antiallergic drugs.
Lorenz W; Doenicke A; Schöning B; Mamorski J; Weber D; Hinterlang E; Schwarz B; Neugebauer E
Agents Actions; 1980 Apr; 10(1 Pt 2):114-24. PubMed ID: 6155762
[TBL] [Abstract][Full Text] [Related]
12. [Bibliographic review of antihistaminics H2 in the treatment of chronic (or recurrent) idiopathic urticaria].
Gay G; Drouet M; Bonneau JC; Le Sellin J; Sabbah A
Allerg Immunol (Paris); 1988 Dec; 20(10):377-8. PubMed ID: 2905603
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic therapy for urticaria.
Negro-Alvarez JM; Carreño-Rojo A; Funes-Vera E; García-Cánovas A; Abellán-Alemán AF; Rubio del Barrio R
Allergol Immunopathol (Madr); 1997; 25(1):36-51. PubMed ID: 9111875
[TBL] [Abstract][Full Text] [Related]
14. H2 blockers in chronic urticaria.
Singh G
Int J Dermatol; 1984 Nov; 23(9):627-8. PubMed ID: 6151554
[TBL] [Abstract][Full Text] [Related]
15. Therapy of cluster headache with histamine H1 and H2 receptor antagonists.
Cuypers J; Altenkirch H; Bunge S
Eur Neurol; 1979; 18(5):345-7. PubMed ID: 43254
[TBL] [Abstract][Full Text] [Related]
16. Retrospective cohort study on combination therapy with the histamine H2-receptor antagonist lafutidine for antihistamine-resistant chronic urticaria.
Ogawa Y; Ichinokawa Y; Hiruma M; Machida Y; Funakushi N; Sadamasa H; Hiruma M
J Dermatolog Treat; 2013 Dec; 24(6):463-5. PubMed ID: 23639034
[TBL] [Abstract][Full Text] [Related]
17. Addition of lafutidine can improve disease activity and lead to better quality of life in refractory cholinergic urticaria unresponsive to histamine H1 antagonists.
Hatakeyama M; Fukunaga A; Washio K; Ogura K; Yamada Y; Horikawa T; Nishigori C
J Dermatol Sci; 2016 May; 82(2):137-9. PubMed ID: 26896422
[No Abstract] [Full Text] [Related]
18. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
Sansom JE; Brooks J; Burton JL; Archer CB
Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
[TBL] [Abstract][Full Text] [Related]
19. Effect of H1 and H2 antagonists on nasal symptoms and mediator release in atopic patients after nasal allergen challenge during the pollen season.
Wang D; Clement P; Smitz J
Acta Otolaryngol; 1996 Jan; 116(1):91-6. PubMed ID: 8820358
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic value of antihistamines today. Dermatoses and allergic diseases of the mucous membranes].
Stüttgen G; Blitstein-Willinger E; Rudolph R
Z Hautkr; 1984 Mar; 59(6):355-66. PubMed ID: 6144211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
